Skip to navigation

Press Releases

MS TSX: Quote: 3.45 | Change: -0.15 | 01.05.09 | 14:27:00 MST

2007 Press Releases

Date       Title
December 17, 2007       Lilly and BioMS Medical Announce Global Licensing and Development Agreement
December 14, 2007       BioMS International Multiple Sclerosis Trial Receives Eighth Positive Review
December 11, 2007       BioMS Phase III U.S. Multiple Sclerosis Trial Receives First Positive Safety Review
November 12, 2007       BioMS Achieves Enrollment Milestone in U.S. Phase III Multiple Sclerosis Trial
November 7, 2007       BioMS Relapsing-Remitting Multiple Sclerosis Trial Receives 2nd Positive Review
October 31, 2007       BioMS to Present at Acumen Biofin Rodman & Renshaw Healthcare Conference
October 15, 2007       BioMS Presents at the European Committee for Research in Multiple Sclerosis
September 28, 2007       BioMS Medical Announces Third Quarter 2007 Results
September 28, 2007       BioMS Medical to Present at BioContact 2007
August 20, 2007       BioMS Medical Announces its Intention to Renew a Normal Course Issuer Bid
August 14, 2007       BioMS Medical Announces Second Quarter 2007 Results
July 24, 2007       BioMS Relapsing-Remitting Multiple Sclerosis Trial Receives Positive Review
June 25, 2007       BioMS Medical to Present at 2007 Jefferies Healthcare Conference
June 5, 2007       BioMS Initiates Enrollment in Pivotal U.S. Phase III Multiple Sclerosis Trial
June 4, 2007       Webcast Alert: BioMS Announces its Biotech / Pharma On-line Forum Webcast
May 23, 2007       BioMS Medical Completes Public Offering
May 15, 2007       BioMS Medical Announces First Quarter 2007 Results
May 15, 2007       BioMS Medical to Raise $38,500,000
May 11, 2007       BioMS to Present at Acumen Biofin Rodman & Renshaw 4th Healthcare Conference
May 3, 2007       BioMS Completes Recruitment in Relapsing-Remitting Multiple Sclerosis Trial
April 20, 2007       BioMS Announces Lead Investigator in US Phase III Multiple Sclerosis Trial
April 10, 2007       BioMS Files Preliminary Short Form Prospectus for Proposed $35 Million Offering
April 5, 2007       BioMS Pivotal Multiple Sclerosis Trial Receives Positive Interim Safety Analysis
February 27, 2007       BioMS Follow-on Open-Label MAESTRO-02 Multiple Sclerosis Trial of MBP8298
February 20, 2007       BioMS Medical Announces 2006 Year-End Results
February 9, 2007       BioMS Medical to Present BIO CEO & Investor Conference 2007
January 22, 2007       BioMS Completes Patient Recruitment in Multiple Sclerosis Trial of MBP8298
January 19, 2007       BioMS Medical Cleared By FDA to Initiate Pivotal Phase III Multiple Sclerosis Trial

BioMS News